Bortezomib successfully reduces monoclonal serum free light chain levels in a patient with recurrent myeloma and cast nephropathy in the renal transplant.

Academic Article

Abstract

  • Bortezomib can be used to successfully treat acute kidney injury in the renal transplant allograft due to light chain cast nephropathy from recurrent multiple myeloma.

    • Authors

    Published In

    Author List

  • Kumar V; Elkins S; Gaston RS; Prendergast MB; Reddy V; Cook WJ; Sanders PW

    • Start Page

  • 439

    • End Page

  • 441